Denali Therapeutics Inc. · NASDAQ:DNLI
T. Rowe Price Investment Management, Inc. reported a 5.40% stake in Denali Therapeutics Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
T. Rowe Price Investment Management, Inc. reported a 5.40% stake in Denali Therapeutics Inc., 8,519,192 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 8,519,192
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.40% | 8,519,192 |
Source
Related
- Denali Therapeutics Inc.
- T. Rowe Price Investment Management, Inc.
- Denali Therapeutics Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Jul 8, 2026
- Form 4 · Chin Peter Scott · Sep 9, 2026
- Form 4 · Thornberry Nancy · Sep 4, 2026
- Form 4 · Schuth Alexander O. · Sep 3, 2026
- Form 4 · Watts Ryan J. · Aug 14, 2026
- Form 4 · Schuth Alexander O. · Aug 13, 2026